1. Home
  2. ZBAO vs HOWL Comparison

ZBAO vs HOWL Comparison

Compare ZBAO & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZBAO
  • HOWL
  • Stock Information
  • Founded
  • ZBAO 2015
  • HOWL 2017
  • Country
  • ZBAO China
  • HOWL United States
  • Employees
  • ZBAO N/A
  • HOWL N/A
  • Industry
  • ZBAO
  • HOWL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZBAO
  • HOWL Health Care
  • Exchange
  • ZBAO NYSE
  • HOWL Nasdaq
  • Market Cap
  • ZBAO 104.7M
  • HOWL 87.4M
  • IPO Year
  • ZBAO 2024
  • HOWL 2021
  • Fundamental
  • Price
  • ZBAO $3.00
  • HOWL $1.79
  • Analyst Decision
  • ZBAO
  • HOWL Strong Buy
  • Analyst Count
  • ZBAO 0
  • HOWL 2
  • Target Price
  • ZBAO N/A
  • HOWL $13.50
  • AVG Volume (30 Days)
  • ZBAO 6.1K
  • HOWL 656.6K
  • Earning Date
  • ZBAO 12-03-2024
  • HOWL 11-07-2024
  • Dividend Yield
  • ZBAO N/A
  • HOWL N/A
  • EPS Growth
  • ZBAO N/A
  • HOWL N/A
  • EPS
  • ZBAO 0.06
  • HOWL N/A
  • Revenue
  • ZBAO $25,274,784.00
  • HOWL $3,386,000.00
  • Revenue This Year
  • ZBAO $65.08
  • HOWL N/A
  • Revenue Next Year
  • ZBAO $34.27
  • HOWL $191.98
  • P/E Ratio
  • ZBAO $49.96
  • HOWL N/A
  • Revenue Growth
  • ZBAO 29.25
  • HOWL N/A
  • 52 Week Low
  • ZBAO $2.36
  • HOWL $1.58
  • 52 Week High
  • ZBAO $5.70
  • HOWL $8.19
  • Technical
  • Relative Strength Index (RSI)
  • ZBAO N/A
  • HOWL 32.55
  • Support Level
  • ZBAO N/A
  • HOWL $1.58
  • Resistance Level
  • ZBAO N/A
  • HOWL $2.24
  • Average True Range (ATR)
  • ZBAO 0.00
  • HOWL 0.16
  • MACD
  • ZBAO 0.00
  • HOWL -0.09
  • Stochastic Oscillator
  • ZBAO 0.00
  • HOWL 7.01

About ZBAO ZHIBAO TECHNOLOGY INC

Zhibao Technology Inc is a insurance technology company primarily engaged in providing digital insurance brokerage services in China. 2B2C digital embedded insurance is their innovative business model which They pioneered in China. They provide customized digital insurance solutions for B-side channels (covering a wide range of industries and organizations, including but not limited to Internet platforms, large and medium-sized enterprises, and government agencies, etc.), embedding them into the channel's existing business matrix, and providing the channel with Provide digital insurance brokerage services to C-end customers.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: